Patents/Assignees

Celgene Quanticel Research, Inc.

9 patents in portfolio

US12447171utility2025
Azacitidine in Combination with Venetoclax, Gilteritinib, Midostaurin or Other Compounds for Treating Leukemia or Myelodysplastic Syndrome
0 cites
US12172998utility2024
Histone Demethylase Inhibitors
0 cites
US11987560utility2024
Inhibitors of Lysine Specific Demethylase-1
0 cites
US11890275utility2024
Therapeutic Compounds
0 cites
US11884648utility2024
Histone Demethylase Inhibitors
0 cites
US11884680utility2024
Bromodomain Inhibitors
0 cites
US11679106utility2023
Bromodomain Inhibitor
0 cites
US11639333utility2023
Histone Demethylase Inhibitors
0 cites
US11566004utility2023
Process for the Preparation of Bromodomain Inhibitor
0 cites